This webinar will describe the validated analytical methods for testing cannabinoid and terpene content, and the relevant USP General Chapters (e.g., <232>, <561>) and why, and how to get more information to aid in ensuring cannabis quality. The presentation will highlight the complementary nature of the proposed GC <1568> to the FDA guidance on cannabis quality for clinical research.
Subject area:
Dietary Supplements & Herbal Medicines
Objectives (If applicable):
N/A
Target Audience (If applicable):
Clinical trial investigators and researchers, cannabis research material providers and the testing labs that may support these groups